Design and rationale of the efficacy of endothelin receptor antagonism in treatment of coronary artery spasm: a randomized controlled trial (EDIT-CAS).

Back

ESC2025 Premium Access

Design and rationale of the efficacy of endothelin receptor antagonism in treatment of coronary artery spasm: a randomized controlled trial (EDIT-CAS).

Session: A deep dive into coronary physiology

Topic: Coronary Vasoreactivity Testing

Speaker: Ms C. Crooijmans (Nijmegen, NL)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Ms Caia Crooijmans

Radboud University Medical Centre, Nijmegen (Netherlands (The))

0 follower

7 more presentations in this session

Minimum lumen area indexed to left ventricular mass to identify functionally-significant left main coronary stenoses: the ARMYDA FINISH study

Speaker: Doctor L. Grisafi (Novara, IT)

Invasive coronary function testing changes management in patients with ANOCA - an analysis of a multicentre experience in the UK

Speaker: Doctor J. Abramik (Bristol, GB)

Coronary flow indices after percutaneous coronary intervention in relation to major adverse cardiovascular events at long-term follow-up in chronic coronary syndrome

Speaker: Mr A. Fedchenko (Stockholm, SE)

Fractional flow reserve in multivessel disease: impact of coronary revascularization on the hemodynamic relevance of parallel stenoses

Speaker: Mr J. Altstidl (Erlangen, DE)

Association of dyslipidemia with coronary artery spasm as assessed by an intracoronary acethycholine provocation test

Speaker: Doctor M. Susanti (Jawa Timur, ID)

Access the full session

A deep dive into coronary physiology

Speakers: Ms C. Crooijmans, Doctor L. Grisafi, Doctor J. Abramik, Mr A. Fedchenko, Mr J. Altstidl...

Access

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources